A delegation of clients from the Democratic Republic of the Congo visited Chenyu Group for an inspection and exchange

On June 24, 2026, several overseas clients from the Democratic Republic of the Congo made a special visit to Chenyu Group to inspect the company's production and R&D capabilities on the spot and have in-depth discussions on cooperation in the West African market. The company's responsible person accompanied and received the visitors throughout the process, personally providing detailed explanations to the visiting clients.

During the inspection, the client successively visited the equipment assembly workshop, the 100,000-level clean reagent production workshop and the standardized R&D laboratory. The person in charge demonstrated on the spot the core instruments such as the five-category blood analyzer and POCT equipment, explained the core technologies of the products, the production process flow, and the full-process quality control standards, and showcased the complete industrial chain from R&D, production to quality inspection. The customer closely observed the entire process of reagent preparation and instrument assembly, and highly recognized our company's strict production standards and stable product performance.

The atmosphere during the symposium was harmonious. Both sides had in-depth exchanges on the current medical situation in the Democratic Republic of the Congo, the demand for grassroots testing equipment, reagent supply, and after-sales support. The customer inquired in detail about the product compatibility plan, supply cycle and localization cooperation model, expressing a strong intention to cooperate. The person in charge, in light of the characteristics of the medical market in West Africa, introduced the enterprise's export supporting services in a targeted manner. Both sides exchanged market development ideas and reached several preliminary cooperation consensations.

This visit is a full recognition of the product strength of Chenyu by the overseas market. In the future, the group will continue to focus on the African IVD market, export high cost-performance diagnostic equipment and matching reagents, build a long-term international cooperation bridge, and work hand in hand with overseas partners for win-win development.